Sponsor:
Neuronetrix, Inc.
Code:
NCT05869032
Conditions
Healthy
Eligibility Criteria
Sex: All
Age: 20 - 59
Healthy Volunteers: Accepted
Brief summary:
Conditions
Healthy
Study ID
NCT05869032
Start date
May 22, 2023
Status verified date
Mar, 2024
Completion date
Sep 30, 2024
Anticipated
Primary completion date
Jul 31, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 20 - 59
Healthy Volunteers: Accepted
Enrollment
80 participants
Anticipated
Arms
Cohort 1 (n=10)
Cohort 2 (n=10)
Cohort 3 (n=10)
Cohort 4 (n=10)
Cohort 5 (n=10)
Cohort 6 (n=10)
Cohort 7 (n=10)
Cohort 8 (n=10)
Primary outcome measure
Central contacts
Locations
Cognision
Recruiting
Louisville, Kentucky, United States, 40214
Contacts
Principal Investigator:
Marco Cecchi, PhD
Sponsor
Neuronetrix, Inc.
Last update posted
Mar 29, 2024
Last verified
Mar, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Neuronetrix, Inc. on 2024-03-29.